Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors
(Q28272076)
scientific article
scientific article
Language:
Current Data About
Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors
| (P31) |
(Q13442814)
|
||||||||||
| (P304) |
5-20
|
||||||||||
| (P407) |
(Q1860)
|
||||||||||
| (P478) |
28
|
||||||||||
| (P577) |
+1989-00-00T00:00:00Z
|
||||||||||
| (P1433) |
(Q27711624)
|
||||||||||
| (P1476) |
"Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors" (language: en)
|
||||||||||
| (P2093) |
M Da Prada
R Kettler
H H Keller
W P Burkard
W E Haefely
|
||||||||||
| (P13046) |
(Q7318358)
|